13F Insight
DOSSIER · 13F Holders · Q1 2026

DRUGS MADE IN AMER ACQ II CO

15 institutions still hold DRUGS MADE IN AMER ACQ II CO as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP G2851K120·15 13F holders·last filed Mar 31, 2026
Market cap
—
13F value held
$45M
visible holders
Holders
15
filers reporting
Concentration
44.81%
LMR Partners LLP #1
top holder share
AI Holders Summary · Q1 2026

15 institutions reported DRUGS MADE IN AMER ACQ II CO in Q1 2026. LMR Partners LLP leads at 44.8% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
LMR Partners LLP
CIK 0001578621
$20M2.0M0.04%Q1 202602
Westchester Capital Management, LLC
CIK 0001512805
$5M503K0.23%Q1 202603
TIG Advisors, LLC
CIK 0001358253
$5M500K0.23%Q1 202604
BlueCrest Capital Management Ltd
CIK 0001610880
$3M250K0.15%Q1 202605
Verition Fund Management LLC
CIK 0001454027
$3M250K0.02%Q1 202606
Kepos Capital LP
CIK 0001512020
$2M210K3.44%Q1 202607
Clear Street Group Inc.
CIK 0001881567
$2M167K0.01%Q1 202608
HRT FINANCIAL LP
CIK 0001475597
$1M137K0.00%Q4 202509
L1 Global Manager Pty Ltd
CIK 0001878742
$1M100K0.67%Q1 202610
Walleye Capital LLC
CIK 0001758720
$1M100K0.00%Q1 202611
READYSTATE ASSET MANAGEMENT LP
CIK 0001900923
$1M100K0.04%Q4 202512
MASO CAPITAL PARTNERS Ltd
CIK 0001698093
$995K100K1.63%Q3 202513
Rangeley Capital, LLC
CIK 0001517796
$327K56K0.32%Q1 202614
ROBINSON CAPITAL MANAGEMENT, LLC
CIK 0001599795
$151K15K0.06%Q1 202615
UBS Group AG
CIK 0001610520
$18K2K0.00%Q1 2026